We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Galson Seeks Expansion of User Fees, New Fee Formula For PDUFA
Galson Seeks Expansion of User Fees, New Fee Formula For PDUFA
April 12, 2006
The FDA is calling for two major reforms to its prescription drug user fee program: the ability to use industry fees for an extended postmarket review period and a formula for tying fees to the amount of work the agency must do, according to a high-ranking FDA official.